Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain
about
Preventing olanzapine-induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatmentAn evaluation of the effects of the novel antipsychotic drug lurasidone on glucose tolerance and insulin resistance: a comparison with olanzapineMetabolic side-effects of the novel second-generation antipsychotic drugs asenapine and iloperidone: a comparison with olanzapine.Sex differences in cannabinoid-regulated biology: A focus on energy homeostasisBrain stem as a target site for the metabolic side effects of olanzapineReduced Brain Cannabinoid Receptor Availability in Schizophrenia.Olanzapine activates hepatic mammalian target of rapamycin: new mechanistic insight into metabolic dysregulation with atypical antipsychotic drugs.Molecular and cellular regulation of hypothalamic melanocortin neurons controlling food intake and energy metabolism.MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management.Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model.Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes.Hypothalamic ghrelin signalling mediates olanzapine-induced hyperphagia and weight gain in female rats.Olanzapine-induced early cardiovascular effects are mediated by the biological clock and prevented by melatonin.Decreased 5-HT2cR and GHSR1a interaction in antipsychotic drug-induced obesity.Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial.Disrupted sphingolipid metabolism following acute clozapine and olanzapine administration.Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects.Metabolic Syndrome and Antipsychotics: The Role of Mitochondrial Fission/Fusion Imbalance.Endocannabinoid Signaling at Hypothalamic Steroidogenic Factor-1/Proopiomelanocortin Synapses Is Sex- and Diet-Sensitive.
P2860
Q28541531-D3B68CAD-7E5E-4CE9-B4F4-ED90E0F0E6E1Q28543222-8F27E146-BB59-4E55-A808-61D74ECC653CQ30459096-E20059D6-3D3B-423D-9A7E-E4E1B45EBBFAQ36665240-E5DA988D-F07C-4BF0-885D-2A7BDEBEB1B2Q36729872-A857520D-5BF8-4E17-9AB7-23E5A7AF77B9Q36945634-70E2182E-7C43-4793-A417-FF243A547171Q37193192-FC485100-38D2-4A44-8DBE-90D46F4BB089Q38204626-2D53F4C8-3B0F-4A35-92B1-18E8CEEA94B3Q38267957-D476F395-EFBA-495E-954E-1A6B903CD307Q38504254-31FC8F66-CCB9-44D3-9784-DDCC3657E918Q40320924-B5F29889-7BD4-4D5F-80ED-8C1FD1E11268Q41441546-9EA8B55D-9D7F-4BCE-B893-247937E7B9D3Q47165661-669A48AA-49A7-4476-8F9E-F3235ECC2E39Q47186524-8450E81E-A2C5-4EDF-AE68-D0F5CB81F574Q47793695-7FEA79BB-F430-47D5-9AA8-73B3DA2C845EQ48336234-AC02D856-D294-4F80-9FD4-FC6A2CC403A5Q50654258-C757715B-30F1-4399-8BAE-9EFE229782A3Q53688865-9B3E6AC2-F9EC-4F91-8672-4F1CDE5E6F5AQ54662194-331E7179-B3F5-43CB-B0BE-64AB26DFE5DEQ55231596-59910579-9E19-419F-B644-99BDB062842BQ55408788-54771F20-C470-4BC5-A1E4-A7A41FA3CD76
P2860
Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Alterations to melanocortinerg ...... olanzapine-induced weight gain
@ast
Alterations to melanocortinerg ...... olanzapine-induced weight gain
@en
Alterations to melanocortinerg ...... olanzapine-induced weight gain
@en-gb
Alterations to melanocortinerg ...... olanzapine-induced weight gain
@nl
type
label
Alterations to melanocortinerg ...... olanzapine-induced weight gain
@ast
Alterations to melanocortinerg ...... olanzapine-induced weight gain
@en
Alterations to melanocortinerg ...... olanzapine-induced weight gain
@en-gb
Alterations to melanocortinerg ...... olanzapine-induced weight gain
@nl
altLabel
Alterations to Melanocortinerg ...... Olanzapine-Induced Weight Gain
@en
prefLabel
Alterations to melanocortinerg ...... olanzapine-induced weight gain
@ast
Alterations to melanocortinerg ...... olanzapine-induced weight gain
@en
Alterations to melanocortinerg ...... olanzapine-induced weight gain
@en-gb
Alterations to melanocortinerg ...... olanzapine-induced weight gain
@nl
P2860
P50
P1433
P1476
Alterations to melanocortinerg ...... olanzapine-induced weight gain
@en
P2860
P304
P356
10.1371/JOURNAL.PONE.0033548
P407
P577
2012-01-01T00:00:00Z